Hepatitis C: Your Path from Diagnosis to Cure Is Research Data

Every figure in this guide comes from a published source, linked where it appears and kept in CureCircle's evidence base with the source's own words. It is not medical advice. Read on 7 November 2026.

Hepatitis C is one of the few chronic infections medicine can now cure with a few weeks of tablets. Yet millions of people are never tested, many are diagnosed years after they were infected, and some wait a long time between a diagnosis and treatment. What got in the way, how the treatment went, and how life and the liver changed afterwards is what research on reaching everyone with hepatitis C still needs, and the person who went through it is the one who can tell it.

How many people live with it

According to the WHO, "globally, an estimated 47 million people have chronic hepatitis C virus infection, with about 0.9 million new infections occurring per year".

The records worth keeping

The AASLD and IDSA guidance on simplified hepatitis C treatment describes the tests that leave records:

• Tests before treatment: quantitative HCV RNA, HIV antigen/antibody, and HBsAg tests. The viral load result is the starting point of the record.
• The treatment course: 8 weeks of glecaprevir/pibrentasvir or 12 weeks of sofosbuvir/velpatasvir for most adults.
• The test that confirms the cure: HCV RNA and liver enzyme testing 12 or more weeks after completing treatment.
• Liver scans afterwards for people with cirrhosis: ultrasound surveillance every 6 months after treatment completion.

If you do not have your results or clinic letters, ask the clinic that treated you for a copy.

What sharing it is worth

CureCircle values every contribution with a public benchmark built from what health data has sold for. A complete hepatitis C story with the records the guidance lists comes to about $92 per licence on the benchmark today. Every line and its source is on the hepatitis C page.

A licence is not a one-off sale: the same de-identified story can be licensed to several research teams, and you earn a share each time.

People with hepatitis C are also paid for their time directly: a published listing offered hepatitis C patients $40 for a 20-minute online survey.

Private by design

How someone came to have hepatitis C is nobody else's business, and the questions never ask for more than you choose to say. You read the de-identified summary before anything goes anywhere: no names, no place finer than a country, no exact dates, and you can withdraw at any time. How de-identification works, and what it cannot promise.

Start your story, or read what your health data is worth first.